CARD16

Chr 11

caspase recruitment domain family member 16

Also known as: COP, COP1, LLID-114769, PSEUDO-ICE

Enables several functions, including CARD domain binding activity; cysteine-type endopeptidase inhibitor activity; and enzyme binding activity. Involved in cellular response to lipopolysaccharide; negative regulation of interleukin-1 beta production; and regulation of signal transduction. Part of protease inhibitor complex. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
6
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.97
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.97LOEUF
pLI 0.383
Z-score 1.62
OE 0.21 (0.07–0.97)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.47Z-score
OE missense 1.13 (0.97–1.32)
115 obs / 101.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.21 (0.07–0.97)
0≤0.351.4
Missense OE?1.13 (0.97–1.32)
0≤0.61.4
Synonymous OE?1.31
0≤1.21.6
LoF obs/exp: 1 / 4.9Missense obs/exp: 115 / 101.6Syn Z: -1.50

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CARD16 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →